No tinnitus supplement, Lipo-Flavonoid and Arches included, has been shown to work: the one randomised trial involving Lipo-Flavonoid could not show it helped, no published trial has tested Arches, and guidelines advise against supplements.
A 2019 review from Stanford's otolaryngology department catalogued the over-the-counter tinnitus remedies sold in the US and found a wide, varied market in unproven products. All of them made unfounded claims of relief from ear ringing, and most were mixtures of inexpensive, common vitamins, minerals and herbs, sold at a premium over similar products not advertised for tinnitus.
What is in Lipo-Flavonoid
Lipo-Flavonoid Plus, made by Clarion Brands, is a caplet of vitamin C, six B vitamins (thiamin, riboflavin, niacin, B6, B12 and pantothenic acid) and calcium, plus what the label calls the Tisina Complex: choline bitartrate, inositol and a lemon bioflavonoid complex. That is the label as entered in 2020 in the US National Institutes of Health (NIH) Dietary Supplement Label Database, which gives the blend's combined weight but not the amount of each part.
The directions are two caplets three times a day for 60 days, then one caplet three times a day on an ongoing basis, and the label offers a refund if there are no results in 60 days. It calls the product "#1 ENT doctor recommended for tinnitus", carries a note that survey data are on file, and says it is supported by more than 50 years of clinical use. Beside them sits the disclaimer US law requires, saying the FDA has not evaluated the statements.
What the research on Lipo-Flavonoid found
The published record is short. Before 2016, a PubMed search for the product's name finds one paper, a 1970 report on lipoflavonoids in Ménière's disease with no abstract indexed.
In 2016 a University of Iowa team published the only randomised trial involving the product that PubMed lists. It randomised 40 people with tinnitus to take Lipo-Flavonoid Plus with manganese, or Lipo-Flavonoid Plus alone, for six months. Twelve dropped out because of side effects or were lost to follow-up. The results:
- In the Lipo-Flavonoid-only group, none of the 16 participants improved on the tinnitus questionnaires. Two reported quieter tinnitus and one reported less annoyance.
- In the manganese group, one of 12 improved on the questionnaires and another on loudness and annoyance ratings.
The authors could not conclude that either manganese or Lipo-Flavonoid Plus is an effective treatment for tinnitus. One limit belongs with that: Lipo-Flavonoid was the comparison arm and there was no placebo group, so the trial cannot measure the product against nothing. Sixteen people is a small group, but none of them improving on a questionnaire over six months is not the pattern you would expect from an effective product.
The same team also surveyed people with tinnitus online. Of 1,788 respondents from 53 countries, 413 (23.1%) had taken supplements, lipoflavonoids among the most common. Among supplement users, 70.7% reported no effect on their tinnitus, 19.0% improvement and 10.3% worsening. Respondents reported lipoflavonoids as somewhat helpful for sleep and emotional reactions, and the authors cautioned that many may have reported a benefit because they were committed to the treatment and expected one. Their conclusion was that dietary supplements should not be recommended to treat tinnitus.
Is there reason to expect a bioflavonoid to help at all? In the Blue Mountains Hearing Study, 1,217 adults aged 50 and over without tinnitus had their diets assessed and were followed for 10 years. Over that time 222 developed tinnitus, and the authors concluded that their findings did not support dietary flavonoids protecting against it. That was food, not a supplement, and observational, but it gives the premise no support.
What is in Arches Tinnitus Formula
According to the manufacturer's product page, checked in September 2026, each two-capsule serving contains 240 mg of a proprietary ginkgo extract, 15 mg of zinc picolinate and 300 mg of deodorised garlic, taken twice a day. A 100-capsule bottle costs $39.95, which at that dose lasts 25 days. The page says to take it for 100 days, four bottles, to judge the effect, sells a four-bottle starter kit for $129.80, and describes the formula as recommended by thousands of ENT doctors and made from clinically proven ingredients.
No trial of the product has been published. Tinnitus UK, a charity that assesses tinnitus products, found no papers on it. It rated Arches as having evidence that it is not effective and evidence of risk of significant harm, citing ginkgo's potential side effects, allergic reactions and drug interactions.
The ingredients have been tested one at a time:
- Ginkgo. The 2022 Cochrane review, 12 trials with 1,915 participants, found ginkgo may make little or no difference to tinnitus severity compared with placebo, on very uncertain evidence. The ginkgo article covers it, including a 2026 Korean guideline that says ginkgo may be considered, on evidence it describes as mostly low or very low certainty.
- Zinc. The 2016 Cochrane review of three placebo-controlled trials with 209 participants found no evidence that oral zinc improves tinnitus in adults. Magnesium and zinc covers it in detail. The Arches page cites a zinc study in which tinnitus severity fell in 82% of patients, without saying whether that study had a placebo group.
- Garlic. A PubMed search in September 2026 found no trial of garlic for tinnitus.
The pills sold through their own websites
Another group of products, with names such as Quietum Plus, Tinnitus 911 and Synapse XT, is sold through the makers' websites. In reviews last updated in April 2023, Tinnitus UK found no published research on any of the three and no evidence that their listed ingredients treat tinnitus, and noted how similarly they were marketed. Each was then on sale for about $69 for a month's supply.
The ingredient lists are the stranger part. The NIH label database holds two labels called Quietum Plus, from different companies, both sold for ear ringing or tinnitus:
- one, entered in April 2025 and since marked off the market, lists vitamin B6, biotin, magnesium and zinc with saw palmetto, nettle, pumpkin, eleuthero, uva ursi and muira puama
- the other, entered in August 2025, lists turmeric, glucosamine, chondroitin, ginger, boswellia, methylsulfonylmethane, quercetin, methionine and bromelain
They share no ingredient. Tinnitus UK's review listed a third set, including yam, fenugreek, dong quai, black cohosh and kelp, and it found the same kind of mismatch with Synapse XT, whose website and label image listed different ingredients. A product whose contents change while its name stays the same cannot be evaluated, and a result for one version would say nothing about another.
Tinnitus has also appeared in federal enforcement. In 2020 the Federal Trade Commission settled with the marketers of Regenify and Resetigen-D, supplements it said were advertised to older Americans as treatments for arthritis, tinnitus, asthma, high cholesterol, psoriasis and eczema. The FTC alleged fake doctor endorsements and fake consumer testimonials. The settlement set a judgment of more than $38.1 million, partially suspended once the defendants paid $1.3 million.
Why "ENT recommended" is not evidence
The Stanford review singled out Arches and Lipo-Flavonoid for marketing to ear, nose and throat surgeons directly, by advertising in specialty journals and prominently featuring supposed endorsement by ENT doctors. The authors called that troubling, and suggested the journals consider declining supplement advertisements that make unproven therapeutic claims.
A recommendation, even a real one, is a survey of opinion rather than a trial. And the specialty's own guideline goes the other way: the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) tinnitus guideline recommends against ginkgo, melatonin, zinc or other dietary supplements for persistent, bothersome tinnitus.
What the evidence says about supplements as a group
The most recent systematic review, published in 2026 in Laryngoscope Investigative Otolaryngology, gathered randomised trials of oral over-the-counter treatments that measured the Tinnitus Handicap Inventory. It found nine trials with 390 adults, testing melatonin, ginkgo, alpha-lipoic acid, açaí extract and several combination formulas. Studies ranged from 12 to 104 people, and most products had been tested only once. Several reported improvement within the treated group, but results were inconsistent and placebo groups often improved too.
The reviewers could not pool the trials, and concluded that no over-the-counter therapy can be recommended as an evidence-based treatment for tinnitus, alone or alongside other treatment. Neither Lipo-Flavonoid nor Arches was among the trials they included.
The 2024 VA/DoD guideline reaches the same place: it suggests against ginkgo, dietary or herbal supplements and nutraceuticals for tinnitus management, a weak recommendation against.
Why a supplement can seem to help
Placebo groups in these trials often improved, and the Iowa survey authors named expectation as a possible reason for many positive reports. A result with no comparison group cannot separate the two, and one of the newest studies shows the problem. It gave a nine-ingredient supplement to 30 people for 90 days with no control group; their Tinnitus Handicap Inventory scores fell from 40.8 to 30.9, and the authors concluded the supplement was associated with better quality of life. Without a placebo group, that fall cannot be attributed to the capsule. The patterns that make a weak tinnitus result look strong sets out this one and others.
Are tinnitus supplements safe?
In the US, no regulator approves them before sale. Under US law the FDA does not have the authority to approve dietary supplements before they are marketed, and a firm generally does not have to give the agency its safety evidence. The disclaimer on the label is there because only a drug can legally claim to diagnose, treat, cure or prevent a disease.
In the Iowa survey, 36 respondents reported adverse effects, including bleeding, diarrhoea and headache. The Arches page itself warns that ginkgo has a mild anticoagulant effect, and tells people on anticoagulants or with bleeding problems to consult a physician first. Tinnitus UK flagged ingredients with known risks in one online product, including black cohosh, which can affect the liver, and kelp, which can affect the thyroid.
Before buying anything sold for tinnitus
The American Tinnitus Association, which sells and endorses no products, published a list of red flags in August 2026. Among them:
- a claim that a cure exists, or that one product treats a range of health conditions
- a legitimate study cited as if it tested the product, when it did not
- no peer-reviewed research on the product itself, only on an ingredient
- testimonials and before-and-after claims with no independent reviews elsewhere
- "FDA Registered" on the label, which says nothing about effectiveness
- countdown timers, repeated upsells before checkout, and surprising celebrity endorsements, including AI-generated ones
- the FDA disclaimer printed next to marketing that implies a cure
The ATA suggests reporting deceptive marketing to the FTC at ReportFraud.ftc.gov, and a serious reaction to the FDA's Safety Reporting Portal. For a product with nothing published about it, checking a treatment yourself shows how to run the search.
When a supplement is the right question
Correcting a measured deficiency is a different act from supplementing for tinnitus. If a blood test shows low vitamin B12, vitamin D or iron, treating it has its own justification. The Iowa authors also thought some supplements are likely to help some people sleep, which is the narrower case for melatonin.
Some tinnitus needs examining before anything is bought. The AAO-HNS guideline asks for a prompt hearing assessment when tinnitus is in one ear, has lasted six months or more, or comes with hearing difficulty, and NIDCD advises treating sudden hearing loss as a medical emergency. The when to seek care checker sorts through the warning signs.
What has better evidence
The same AAO-HNS guideline recommends cognitive behavioural therapy for persistent, bothersome tinnitus and a hearing aid evaluation where hearing loss is documented, and lists sound therapy as an option. The treatment comparison sets them beside the rest, and whether tinnitus can be cured covers what they can realistically achieve.